# US 2025/0297301 A1 · Single-stranded end preserving adaptors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0297301 A1
- Document ID: US20250297301A1
- Status: Published application
- Kind: A1
- Application number: 19/060,201
- Filed: 2025-02-21
- Published: 2025-09-25
- Earliest claimed: 2024-02-22
- Assignees: Canal Biosciences, Inc.
- Applicants: Canal Biosciences, INC
- Inventors: Yu ZHENG
- Web page: https://patentgrep.com/patent/US20250297301A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12N 9/1205: {Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases}
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 9/2497: {hydrolysing N- glycosyl compounds (3.2.2)}
- C12N 9/93: {Ligases (6)}
- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- C12Q 1/6855: Ligating adaptors
- C12Q 1/6869: Methods for sequencing
- C12Y 207/01078: Polynucleotide 5'-hydroxyl-kinase (2.7.1.78)
- C12Y 605/01003: RNA ligase (ATP) (6.5.1.3)
- C12Q 2521/501: Ligase
- C12Q 2525/186: incorporating a non-extendable or blocking moiety
- C12Q 2525/191: incorporating an adaptor
- C12Q 2531/113: PCR
- C12Q 2535/122: Massive parallel sequencing
- C12Q 2563/179: the label being a nucleic acid
- C12Y 301/21007: Deoxyribonuclease V (3.1.21.7)
- C12Y 302/02027: Uracil-DNA glycosylase (3.2.2.27)
- C12Y 605/01: forming phosphoric ester bonds (6.5.1)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Provided herein are compositions, kits, systems, and methods employing single-stranded end-preserving adaptors. Such single-stranded adaptors are attached to DNA duplex molecules while preserving original 5′ or 3′ single-strand protruding ends (e.g., present in cell-free DNA) by attaching such adapters to 3′ ends the DNA duplex molecules using a single strand ligase that has step 3 ligase activity, but not step 2 adenylyl transfer activity, and attaching such adapters to 5′ ends of the DNA duplex molecules using a ligase enzyme (e.g., a circligase), thereby forming loop-like structures on one or each end of the DNA duplex molecules. In further embodiments, the loop-like structures are cleaved (e.g., by an endonuclease) as the single-stranded adapters have a cleavable portion, thereby generating a two-part adapter on one or both ends of the DNA duplex molecules that preserves the initial 5′ or 3′ single-strand protruding ends, along with any methylation present.

## Claims

### Claim 1

A kit comprising:
a) a plurality of single-stranded adaptors, wherein each of said single-stranded adaptors comprises a nucleic acid sequence and optionally a 3′ end blocking group attached to the 3′ end of said nucleic acid sequence, wherein said 3′ end blocking group is optionally a modified non-canonical nucleotide or a phosphate group,
wherein the 5′ end of said nucleic acid sequence is adenylated, and
wherein said nucleic acid sequence comprises: a 5′ region, a 3′ region, and a cleavable region between said 5′ and 3′ regions, and is optionally methylated at every, or nearly every, cytosine present in said nucleic acid sequence; and
b) a single strand ligase, wherein said single strand ligase has step 3 ligase activity, but not step 2 adenylyl transfer activity.

### Claim 2 (depends on 1)

The kit of claim 1, wherein said cleavable region comprises: A) a modified non-canonical base, B) a nucleic acid backbone linkage, or C) an endonuclease recognition site, wherein endonuclease recognition site is formed at the junction of said 5′ and 3′ regions or is composed of a sequence between said 5′ and 3′ regions, or D) one or more RNA bases, wherein optionally the rest of the first and second nucleic acid sequences are composed of DNA, or E) comprises a sequence that forms a endonuclease recognition sequence when a secondary oligonucleotide is added.

### Claim 3 (depends on 1)

The kit claim 1, wherein said single strand ligase is a thermostable lysine-mutant ssDNA/RNA ligase which is a mutated version of a precursor thermostable ssDNA/RNA ligase, wherein said precursor thermostable ssDNA/RNA ligase has a Motif I EKx(D/N/H) G, and wherein said thermostable lysine-mutant replaces K in said Motif I with any other amino acid or is selected from alanine (A), serine(S), cysteine (C), valine (V), threonine (T), and Glycine (G).

### Claim 4 (depends on 1)

The kit of claim 1, wherein said single strand ligase has an amino acid sequence that is 95% or 100% identical to any one of SEQ ID NOs: 1-21.

### Claim 5 (depends on 1)

The kit of claim 1, wherein said 5′ and 3′ regions of said first nucleic acid sequence each comprise at least one element selected from: a flow cell attachment sequence, a unique barcode sequence, a non-unique barcode sequence, a sample-identifying index sequence, a read 1 primer binding sequence, a read 2 primer binding sequence, and a universal PCR amplification primer binding sequence.

### Claim 6 (depends on 1)

The kit of claim 1, wherein said 5′ and 3′ regions of said first nucleic acid sequence each comprise a barcode sequence that have predefined relationship to each other, which is optionally based on a pre-defined association which may be a look up table, and optionally wherein said barcodes sequences are non-complementary to each other, and optionally where the barcodes are of different lengths.

### Claim 7 (depends on 1)

The kit of claim 1, wherein said 3′ end blocking group is present.

### Claim 8 (depends on 1)

The kit of claim 1, wherein said 3′ end blocking group is selected from: a nucleotide with 3′-phosphate group and a nucleotide reversible terminator.

### Claim 9 (depends on 1)

The kit of claim 1, further comprising a deblocking agent.

### Claim 10 (depends on 1)

The kit of claim 1, further comprising a ligase enzyme selected from: Circligase I, Circligase II, RtcB ligase from E. coli. or homologs, thermostable RtcB or homologs, TS2126 RNA ligase, and Mth DNA ligase, T4 RNA ligase 1, and T4 RNA ligase 2.

### Claim 11 (depends on 1)

The kit of claim 1, further comprising one or more enzymes capable of cleaving said cleavable region of said nucleic acid sequence.

### Claim 12 (depends on 11)

The kit of claim 11, wherein said one more enzymes, or reagent, are selected from: an endonuclease, endonuclease V, endonuclease VIII, an endonuclease and uracil DNA glycosylase, and thermostable oxoguanine glycosylase (OGG), and iodine.

### Claim 13 (depends on 1)

The kit of claim 1, further comprising a plurality of DNA duplex molecules, wherein each of said DNA duplex molecule comprise: i) a first duplex end that comprises a 3′ strand end and a 5′ strand end, and has a 3′ or 5′ single-strand protruding end that is either a single non-adenine nucleotide or is at least two nucleotides in length, and ii) a second duplex end that comprises a 3′ strand end and a 5′ strand end which optionally has a 3′ or 5′ single-strand protruding or blunt end, and optionally wherein any of, or all of, said protruding ends comprise at least one cytosine that is methylated.

### Claim 14 (depends on 13)

The kit of claim 13, wherein each of said DNA duplex molecules comprises a loop-like structure on the first duplex end and second duplex end, wherein said loop-like structure is composed of said nucleic acid sequence.

### Claim 15 (depends on 1)

The kit of claim 1, further comprising one or more containers for collectively or separately holding the recited components, optionally, wherein said components are present inside said container.

### Claim 16 (depends on 15)

The kit of claim 15, wherein said one or more containers is selected from a cardboard box, a plastic bag or box, glass vials, and plastic vials.
